A 12-week Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase 2 Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis followed by an Open-label Extension Phase.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
79
Proportion of Subjects Achieving a 50% Reduction in PPPASI Score
In the Palmoplantar Pustulosis Psoriasis Area and Severity Index (PPPASI), the left palm, right palm, left foot, and right foot are assessed based on 3 target symptoms: erythema, desquamation (scaling), and pustules, as seen on the day of the examination. The severity of each sign is assessed using a 5-point scale (0 = not present, 1 = slight, 3 = moderate, 4 = severe, 5 = very severe). The affected area within a given anatomic site (left palm, right palm, left foot, and right foot) is estimated as a percentage of the total area of that anatomic site and assigned a numerical value according to the degree of PPP involvement (0 = no involvement, 2 = 10 to less than 30% involvement, 3 = 30 to less than 50% involvement, 4 = 50 to less than 70% involvement, 5 = 70 to less than 90% involvement, 6 = 90 to less than 100% involvement). PPPASI score for palms and soles is obtained using a formula and can vary from 0 (absence of disease) to 72 (most severe disease).
Time frame: Baseline to Week 12
Absolute Change From Baseline in PPPGA
Time frame: Baseline to Week 12
Absolute Change From Baseline in PPPASI
Time frame: Baseline to Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Total Skin & Beauty Dermatology Center, PC
Birmingham, Alabama, United States
Dermatology Trial Associates
Bryant, Arkansas, United States
Cosmetic Laser Dermatology
San Diego, California, United States
Clinical Science Institute
Santa Monica, California, United States
Driven Research LLC
Coral Gables, Florida, United States
Encore Medical Research, LLC
Hollywood, Florida, United States
Tory Sullivan, MD PA
North Miami Beach, Florida, United States
Advanced Medical Research PC
Sandy Springs, Georgia, United States
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, United States
DS Research
Louisville, Kentucky, United States
...and 41 more locations